Burkitt lymphoma‑associated network construction and important network motif analysis

Kunhao Wang, Chao Ma, Chong Xing, Chin‑Ling Chen, Zhigang Chen, Yuxia Yao, Jianan Wang, Chunyu Tao
2018 Oncology Letters  
Biological and medical researchers have discovered numerous transcription factors (TFs), microRNAs (miRNAs) and genes associated with Burkitt lymphoma (BL) through individual experiments; however, their regulatory mechanisms remain unclear. In the present study, BL-dysregulated and BL-associated networks were constructed to investigate these mechanisms. All data and regulatory associations were from known data resources and literature. The dysregulated network consisted of dysregulated TFs,
more » ... As and genes, and partially determined the pathogenesis mechanisms underlying BL. The BL-associated network consisted of BL-associated TFs, miRNAs and genes. It has been indicated that the network motif consisted of TFs, miRNAs and genes serve potential functions in numerous biological processes within cancer. Two of the most studied network motifs are feedback loop (FBL) and feed-forward loop (FFL). The important network motifs were extracted, including the FBL motif, 3-nodes FFL motif and 4-nodes motif, from BL-dysregulated and BL-associated networks, and 10 types of motifs were identified from BL-associated network. Finally, 26/31 FBL motifs, 45/75 3-nodes FFL motifs and 54/94 4-nodes motifs were obtained from the dysregulated/associated networks. A total of four TFs (E2F1, NFKB1, E2F4 and TCF3) exhibit complicated regulation associations in BL-associated networks. The biological network does not demonstrate the dysregulated status for healthy people. When the individual becomes unwell, their biological network exhibits a dysregulated status. If the dysregulated status is regulated to a normal status by a number of medical methods, the diseases may be treated successfully. BL-dysregulated networks serve important roles in pathogenesis mechanisms underlying BL regulation of the dysregulated network, which may be an effective strategy that contributes to gene therapy for BL.
doi:10.3892/ol.2018.9010 pmid:30127896 pmcid:PMC6096059 fatcat:7dkw53c74rfhdehnnn67vbwd6i